Exhibit 10.7 Elite Business Machines Manufacturing Company Limited MANUFACTURING AGREEMENT This Manufacturing Agreement ("Agreement") is entered into at Kwun Tong, Kowloon, Hong Kong, on March 10, 2004, between Elite Business Machines Manufacturing...Manufacturing Agreement • August 29th, 2007 • Freehand Information Systems, Inc. • Blank checks • Hong Kong
EXHIBIT 10.1 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. MANUFACTURING AGREEMENT MANUFACTURING AGREEMENT, dated September 10, 2004, by and between CYTOGEN CORPORATION, a...Manufacturing Agreement • September 14th, 2004 • Cytogen Corp • Pharmaceutical preparations • New Jersey
MANUFACTURING AGREEMENTManufacturing Agreement • May 13th, 2014 • Ulthera Inc • Electromedical & electrotherapeutic apparatus • Delaware
This Manufacturing Agreement (this “Agreement”) is made as of January 2nd, 2014 (the “Effective Date”), by and between BIT Group Inc., a California corporation, with offices located at 15870 Bernardo Center Drive, San Diego, CA 92127 (“BIT”), and Ulthera, Inc., a Delaware corporation, with offices located at 1840 S. Stapley Dr., Ste. 200, Mesa, AZ 85204 (“Client”). Individually, BIT and Client may be referred to herein as a “Party” and collectively as “Parties”.
ANDManufacturing Agreement • October 5th, 2001 • Netscreen Technologies Inc
Exhibit 10.1 SECOND AMENDMENT TO MANUFACTURING AGREEMENT This Second Amendment made as of May 13, 2003, to Manufacturing Agreement dated October 1, 2000 between Signore, Inc., a Delaware corporation ("Seller") and American Locker Security Systems,...Manufacturing Agreement • August 12th, 2003 • American Locker Group Inc • Partitions, shelvg, lockers, & office & store fixtures
CLINICAL SUPPLIES MANUFACTURING AGREEMENT BETWEEN HELIX BIOPHARMA CORP. AND BIOVECTRA INC. May 4, 2008 CONFIDENTIAL TREATMENT REQUESTEDManufacturing Agreement • February 5th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
ContractManufacturing Agreement • March 17th, 2008 • APP Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Note: Redacted portions have been marked with (***). The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange Commission.
MANUFACTURING AGREEMENT THIS AGREEMENT, dated as of September 1, 1996, is made and entered into by SEAMED CORPORATION ("Seller") and COINSTAR, INC., a Delaware corporation ("Buyer"). Seller and Buyer agree as follows: SECTION 1. DEFINITIONS Whenever...Manufacturing Agreement • May 9th, 1997 • Coinstar Inc • Washington
CERTAIN IDENTIFIED INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (1) NOT MATERIAL AND (2) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. STREMICK HERITAGE FOODS, LLC and PREMIER...Manufacturing Agreement • September 20th, 2019 • Bellring Brands, Inc. • Food and kindred products • California
THIS MANUFACTURING AGREEMENT (the “Agreement”) is made this first day of July, 2017 (the “Effective Date”) between Stremicks Heritage Foods, LLC (“Heritage”), a Delaware limited liability company with an address of 4002 Westminster Avenue, Santa Ana, CA 92703 and PREMIER NUTRITION CORPORATION (“Premier”), a Delaware corporation with a principal place of business at 5905 Christie Avenue, Emeryville, California 94608 (each a “Party”, collectively, the “Parties”).
Portions of this exhibit were omitted and filed separately with the Secretary of the Securities and Exchange Commission pursuant to an application for confidential treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2...Manufacturing Agreement • July 7th, 2010 • Vishay Precision Group, Inc. • Electronic components & accessories • New York
This MANUFACTURING AGREEMENT (this “Agreement”) is made as of July 6, 2010 by and between Vishay S.A., a French company (“Manufacturer”), and Vishay Precision Foil VPG GmbH, a German company (“Buyer”). Manufacturer and Buyer each may be referred to herein as a “Party” and collectively, as the “Parties”.
MANUFACTURING AGREEMENT DPT LAKEWOOD, LLC AND INSYS THERAPEUTICSManufacturing Agreement • February 27th, 2013 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This Manufacturing Agreement (the “Agreement”) is made as of this 24th day of May, 2011 (the “Effective Date”) by and between Insys Therapeutics, a corporation organized under the laws of the State of Delaware with its principal place of business at 10220 South 51st Street, Suite 2, Phoenix, AZ 85044 (hereinafter referred to as “COMPANY”) and DPT Lakewood, LLC, a corporation organized under the laws of the State of Delaware with a place of business at 1200 Paco Way, Lakewood, New Jersey, 08701, including its affiliate DPT Laboratories, Ltd. (hereinafter collectively referred to as “DPT”).
MANUFACTURING AGREEMENTManufacturing Agreement • April 5th, 2004 • Coca Cola Femsa Sa De Cv • Bottled & canned soft drinks & carbonated waters
By this Agreement, that becomes effective as from April 16th, 1999, on one side, COCA-COLA INDÚSTRIAS LTDA., a private limited liability company, organized according to the country laws, enrolled with the Legal Persons National Registry of the Ministry of Finance under number 45.997.418/0001-53, with headquarters at Praia do Botafogo, 374 - 12o. andar, parte, Rio de Janeiro, State of Rio de Janeiro (hereinafter referred to as “PARTNERSHIP”) and, on the other side, REFRIGERANTES DO OESTE LTDA., enrolled with the Legal Persons National Registry of the Ministry of Finance under number 03.025.988/0001-31, with headquarters at Km 01 of BR-163 (Rod. Campo Grande/Sao Paulo), Campo Grande, State of Mato Grosso do Sul (hereinafter referred to as “MANUFACTURER”); and as Intervening Party, THE COCA-COLA COMPANY, an American Corporation, organized and operating under the laws of the State of Delaware, United States of America (hereinafter referred to as “COMPANY”);
RECITALSManufacturing Agreement • March 4th, 2005 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances) • California
MANUFACTURING AGREEMENT This manufacturing agreement ("Manufacturing Agreement") is made Friday, January 21, 2000 by and between Asia Pacific Micro, Inc. ("APM"), having a place of business at 2071 Mountain Blvd., Suite C, Oakland, California, 94611...Manufacturing Agreement • June 13th, 2000 • Econnect • Services-miscellaneous amusement & recreation • California
MANUFACTURING AGREEMENT between ABBOTT GMBH & CO. KG and RELIANT PHARMACEUTICALS, LLC Dated as of December 3, 2003Manufacturing Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • Illinois
Abbott has agreed to manufacture the Products in accordance with all cGMP’s, Product Specifications and all applicable federal, state, and local laws and regulations.
MANUFACTURING AGREEMENT ----------------------- This Manufacturing Agreement ("Agreement") is entered into this 9th day of Feb/2004 by and between the following parties; 1. Manufacturer: Canadian Phytopharmaceuticals Corp. Address: 12233 Riverside Way...Manufacturing Agreement • March 31st, 2006 • China Health Holding, Inc. • Medicinal chemicals & botanical products • British Columbia
MANUFACTURING AGREEMENTManufacturing Agreement • April 19th, 2018 • Electrameccanica Vehicles Corp. • Motor vehicles & passenger car bodies • Hong Kong
ELECTRAMECCANICA VEHICLES CORP., an entity incorporated under the laws of the Province of British Columbia, Canada, with an address of Suite 102 East 1st Avenue, Vancouver, British Columbia, Canada, V5T 1A4 (“EMV”); AND: CHONGQING ZONGSHEN AUTOMOBILE INDUSTRY CO., LTD., a company organized and existing under the laws of China, with its head office located at: Zongshen Industry Zone Banan District, Chongqing PC: 400054(“Manufacturer”) ELECTRAMECCANICA VEHICLES CORP., （ “EMV”），Suite 102 East 1st Avenue, Vancouver, British Columbia, Canada, V5T 1A4
DSM PHARMA CHEMICALS, INC. and NOVACARDIA, INC. DEVELOPMENT, TECHNOLOGY TRANSFER AND PRE-COMMERCIAL MANUFACTURING AGREEMENTManufacturing Agreement • May 23rd, 2007 • NovaCardia Inc • Pharmaceutical preparations • Delaware
THIS DEVELOPMENT, TECHNOLOGY TRANSFER AND PRE-COMMERCIAL MANUFACTURING AGREEMENT (the "Agreement") is executed as of this 5th day of June, 2006 (the "Effective Date"), by and between DSM Pharma Chemicals North America, Inc., a corporation organized under the laws of the State of Delaware, having a place of business at 45 Waterview Blvd., Parsippany, NJ 07054, and its affiliate, DSM Fine Chemicals Austria Nfg GmbH Co KG, an Austrian corporation, having a place of business at St. Peter Strasse 25, 4021 Linz, Austria (collectively, both DSM parties hereinafter referred to as "DPC"); and NovaCardia, Inc.("NovaCardia"), a corporation organized under the laws of Delaware, having its principal place of business at 12230 El Camino Real, Suite 300, San Diego, California 92130.
AVAIL MEDICAL PRODUCTS, INC. & KINETIC CONCEPTS, INC. AMENDED AND RESTATED MANUFACTURING AGREEMENTManufacturing Agreement • February 23rd, 2004 • Kinetic Concepts Inc /Tx/ • Miscellaneous furniture & fixtures • Texas
This Amended and Restated Manufacturing Agreement (this "Agreement") is made and entered into as of the 18th day of December, 2002, by and between Kinetic Concepts, Inc., a Texas corporation having an address of 8023 Vantage Drive, San Antonio, TX 78230 ("KCI") and Avail Medical Products, Inc., a Delaware corporation with principal offices at 201 Main Street, Suite 1660, Fort Worth, Texas 76102 ("Avail"). It is understood that this Agreement will inure to the benefit of all subsidiaries and affiliates of KCI, as well as KCI (collectively, the "KCI Affiliates") and will be effective as of October 1, 2002 (the "Effective Date").
FIRST AMENDMENT TO STRATEC DEVELOPMENT SERVICES and EQUITY PARTICIPATION AGREEMENT and SECOND AMENDMENT TO SUPPLY and MANUFACTURING AGREEMENTManufacturing Agreement • November 9th, 2017 • Quanterix Corp • Laboratory analytical instruments
This Amendment (the “1st and 2nd Amendment”) is made and entered into effective as of November 18, 2016, by and between Quanterix Corporation, a company organized and existing pursuant to the laws of Delaware, U.S.A. (“QTX”), and STRATEC Biomedical AG, a company organized and existing pursuant to the laws of Federal Republic of Germany (“STRATEC”). QTX and STRATEC each may be referred to herein individually as a “Party”, or collectively as the “Parties”.
MANUFACTURING AGREEMENTManufacturing Agreement • March 5th, 2009 • Attitude Drinks Inc. • Beverages
THIS AGREEMENT is made this 16th day of December, 2008 between O-AT-KA MILK PRODUCTS COOPERATIVE, INC. ("Vendor") and ATTITUDE DRINK COMPANY ("Vendee").
MANUFACTURING AGREEMENTManufacturing Agreement • June 23rd, 2014 • Macrocure Ltd. • Biological products, (no disgnostic substances) • London
This MANUFACTURING AGREEMENT (the “Agreement”), dated as of 26th February, 2014 (the “Execution Date”), is entered into between Maco Productions, a corporation organized under the laws of France, registered at the Trade Register of Lille Métropole under n° 313 777 997 and Represented by Mr. Ronald de Lagrange-Chancel, President and Maco Pharma, a corporation organized under the laws of France, registered at the Trade Register of Lille Métropole under n° 391 600 905 and Represented by Mr. Ronald de Lagrange-Chancel, President (hereinafter called together the “Contractor”), and Macrocure LTD., a corporation organized under the laws of Israel with a principal place of business at 25 Hasivim St. Petach Tikva 49517, Israel (hereinafter called the “Customer”).
SOFTGEL COMMERCIAL MANUFACTURING AGREEMENTManufacturing Agreement • May 23rd, 2014 • Clarus Therapeutics Inc • Pharmaceutical preparations • New Jersey
This Softgel Commercial Manufacturing Agreement (“Agreement”) is made this 23rd day of July, 2009, by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 2725 Scherer Drive, St. Petersburg, Florida 33716 (“Catalent”) and Clarus Therapeutics, Inc., a corporation, having its principal place of business at 500 Skokie Blvd., #250, Northbrook, IL 60062 (“Client”).
RECITALSManufacturing Agreement • March 31st, 2005 • Med-Design Corp • Surgical & medical instruments & apparatus • California
MANUFACTURING AGREEMENTManufacturing Agreement • December 30th, 2014 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Manufacturing Agreement (this “Agreement”) is made this 18th day of March, 2014 (the “Effective Date”) by and between Spark Therapeutics, LLC, a Delaware limited liability company with a principal address at 3501 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA (“Spark”), and Genable Technologies Limited, a limited liability company with a principal address at c/o Delta Partners, Media House, South County Business Park, Leopardstown, Dublin 18, Ireland (“Genable”). Spark and Genable may each be referred to herein as a “Party” and together as the “Parties”.
SITIME - BOSCH AMENDED AND RESTATED MANUFACTURING AGREEMENTManufacturing Agreement • October 23rd, 2019 • SITIME Corp • Semiconductors & related devices • California
This Amended and Restated Manufacturing Agreement (hereinafter the “Agreement”) is entered into as of 23 - Feb, 2017 (the “Effective Date”), by and between SiTime Corporation, a Delaware corporation, having its principal place of business at 5451 Patrick Henry Drive Santa Clara, CA 95054, (“SiTime” or “Buyer”) and Robert Bosch LLC, a Delaware limited liability company having its principal place of business at 38000 Hills Tech Drive, Farmington Hills, Michigan 48331 (“Bosch” or “Seller”). Buyer and Seller each may be referred to individually as a “Party” or collectively as the “Parties.”
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. MANUFACTURING AGREEMENTManufacturing Agreement • June 20th, 2008 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Manufacturing Agreement is effective as of February 6, 2008 (“Effective Date”) by and among Bayer HealthCare, LLC, a Delaware limited liability company with an office at 12707 West Shawnee Mission Parkway, Shawnee, KS 66216 (hereinafter “Bayer”), and Cumberland Pharmaceuticals Inc., a Tennessee corporation, organized under the laws of Tennessee, having its principal place of business at Nashville, TN (hereinafter “Cumberland”) and their products described herein.
ContractManufacturing Agreement • September 9th, 2016 • Everspin Technologies Inc • Semiconductors & related devices • New York
[*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
MANUFACTURING AGREEMENTManufacturing Agreement • November 17th, 2014 • Tower Semiconductor LTD • Semiconductors & related devices
This MANUFACTURING AGREEMENT (this “Agreement”) is entered into as of April 1, 2014 (the “Effective Date”) between PANASONIC CORPORATION, a Japanese corporation having its place of business at 1 Kotariyakemachi, Nagaokakyo City, Kyoto, 617-8520, Japan (“Panasonic”) and TOWERJAZZ PANASONIC SEMICONDUCTOR CO., LTD., having its principal place of business at 800 Higashiyama, Uozu City, Toyama 937-8585, Japan (the “Company”). Panasonic and the Company are referred to herein collectively as the “Parties” and individually as a “Party.”
First Amendment to Contract Manufacturing Agreement (Metreleptin SLD) dated September 30, 2010Manufacturing Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT (“Amendment”) entered into as of September 01, 2011 is by and between Amylin Pharmaceuticals, Inc., whose principal office is at 9360 Towne Centre Drive, San Diego, California 92121 (“Amylin”) and Sandoz GmbH, whose principal office is at Biochemiestrasse 10, A6250 Kundl, Austria (“Sandoz”).
Contract Manufacturing Agreement, Principle To Principle And Loan License Agreements Under Drug LawsManufacturing Agreement • December 30th, 2021
Historically pharmaceutical companies turned to contract manufacturers for achieving efficiencies in cost, capacity and time-to-market, or to obtain specific expertise not available in-house. However, the increment in outsourcing of manufacture is driven, at least in part, by the fact that contract manufacturers have increasingly developed innovative proprietary processes and implemented technology that may well surpass that available at the pharmaceutical client's own facilities. Moreover, nowadays few pharmaceuticals are made in dedicated plants and key intermediates and active compounds can be made in general-purpose plants.
First Amendment to Manufacturing Agreement between DPT Laboratories, Ltd. and Auxilium Pharmaceuticals, Inc.Manufacturing Agreement • July 2nd, 2004 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations
This First Amendment to Manufacturing Agreement (“First Amendment”) between DPT Laboratories, Ltd. (“DPT”) and Auxilium Pharmaceuticals, Inc. (“COMPANY”) is made this 28th day of May, 2002.
MANUFACTURING AGREEMENTManufacturing Agreement • May 12th, 2008 • Photon Dynamics Inc • Instruments for meas & testing of electricity & elec signals • California
This manufacturing agreement (the “Agreement”) is made and entered into on August 3, 2006 (‘Effective Date”) by and between Photon Dynamics, Inc. (“PDF), a California corporation, having its principal office at 5970 Optical Drive, San Jose, California 95138, and Ultra Clean Technology Systems and Service, Inc. a corporation organized and existing under the laws of the State of California having its principal office at 150 Independence Drive, Menlo Park, CA 94025 and its affiliates (Collectively “the “Manufacturer”). PDI and Manufacturer are each individually referred to herein as the “Party” and collectively as the “Parties.”
SITIME - BOSCH AMENDMENT NO.1 TO AMENDED AND RESTATED MANUFACTURING AGREEMENTManufacturing Agreement • October 23rd, 2019 • SITIME Corp • Semiconductors & related devices
This Amendment No. 1 to Amended and Restated Manufacturing Agreement (this “Amendment”) is entered into as of August 1, 2018 (the “Effective Date”), by and between SiTime Corporation, a Delaware corporation, having its principal place of business at 5451 Patrick Henry Drive Santa Clara, CA 95054, (“SiTime” or “Buyer”) and Robert Bosch LLC, a Delaware limited liability company having its principal place of business at 38000 Hills Tech Drive, Farmington Hills, Michigan 48331 (“Bosch” or “Seller”). Buyer and Seller each may be referred to individually as a “Party” or collectively as the “Parties.”
Manufacturing Agreement Between Sonos, Inc. And IACManufacturing Agreement • July 6th, 2018 • Sonos Inc • Household audio & video equipment • California
This Manufacturing Agreement, including the Exhibits (“Agreement”), effective as of September 4, 2014 (“Effective Date”), is by and between Sonos, Inc., a Delaware corporation, having its principal offices at 223 E. De La Guerra Street, Santa Barbara, CA, 93101, USA (“Sonos”), and Inventec Appliances Corporation, having principal offices at 37, Wugong 5th Road, Wugu District, New Taipei City, 24890, Taiwan, R.O.C. (“IAC”).
